Bleichroeder’s Ernexa Therapeutics ERNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-80,000
Closed -$398K – 81
2026
Q1
$398K Buy
+80,000
New +$1.28M 0.07% 52

Other funds holding ERNA

Bleichroeder's ERNA Position: Q2 2026 in Review

Bleichroeder sold out of Ernexa Therapeutics (ERNA) in Q2 2026, closing a stake of 80,000 shares — an estimated $398K sold.

Bleichroeder first reported a position in ERNA in Q1 2026 and held it in 1 quarter. The position peaked at $398K in Q1 2026. 9 funds tracked by Wall St. Rank hold ERNA as of Q2 2026.

  • Bleichroeder reported no remaining Ernexa Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Bleichroeder sold 80,000 Ernexa Therapeutics shares in Q2 2026, an estimated $398K.
  • Bleichroeder first reported a position in Ernexa Therapeutics in Q1 2026 and held it in 1 quarter.
  • Bleichroeder's Ernexa Therapeutics position peaked at $398K in Q1 2026.
  • 9 funds tracked by Wall St. Rank held Ernexa Therapeutics as of Q2 2026.

Based on Bleichroeder's 13F filing for Q2 2026, filed 13 Aug 2026.